CTOs on the Move

Onyx Pharmaceuticals

www.onyx.com

 
At Onyx Pharmaceuticals, an Amgen subsidiary, our imperative is to build a leading cancer therapeutics company like no other, working toward a unified goal that drives us forward…to deliver breakthrough cancer treatments to patients with the urgency they deserve.   By working in collaboration with patient advocacy groups, healthcare providers and business partners, we push the boundaries of science and cancer therapeuticdevelopment.
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.onyx.com
  • 249 E. Grand Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.266.0000

Executives

Name Title Contact Details

Similar Companies

QRxPharma Limited

QRxPharma Limited is a Bedminster, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SST Corporation

SST Corporation is a Clifton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Affinium Pharmaceuticals

Affinium Pharmaceuticals , Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

U.S MAX HEALING PRODUCTS,INC

U.S MAX HEALING PRODUCTS,INC is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HEXO Corporation

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, UP Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint venture with Molson Coors. In the event that the previously announced transactions to acquire 48North and Redecan close, HEXO expects to be the number one cannabis products company in Canada by recreational market share.